Elliot L Chaikof

This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Biomaterials Innovation. Top assignees: Emory University, Beth Israel Deaconess Medical Center, Inc., University of Toronto. Active years: 1990-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elliot L Chaikof. Retrieved from https://idiyas.com/inventor/elliot-l-chaikof

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 6)

% Patents Active = 73.7

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 571(Granted Patents)

Location History:

Donwoody, GA (US) (2000 - 2001)
Dunwoody, GA (US) (1998 - 2010)
Atlanta, GA (US) (2005 - 2015)
Newton, MA (US) (1990 - 2023)

Company Filing History:

Beth Israel Deaconess Medical Center, Inc.

patents

2 out of 533

University of Toronto

patents

4. 1 out of 9

Baker Idi Heart and Diabetes Institute Holdings Limited

patents

5. 1 out of 2,197

Georgia Tech Research Corporation

patents

6. 1 out of 8,600

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 1990-2024

Loading Chart...

Areas of Expertise:

Selectin Inhibitors

Aryl Hydrocarbon Receptor

Fluidic Systems

Polymeric Materials

Temperature Sensitive Compositions

Modified Protein Polymers

Thrombomodulin Derivatives

Biological Components

Glycopolymers

Antithrombogenic Membranes

Cytomimetic Biomaterials

Self-Expanding Prosthesis

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162960 - Selectin inhibitors, composition, and uses related thereto (2024-12-10),

2. 12152016 - Aryl hydrocarbon receptor modulators and uses thereof (2024-11-26),

3. 12103216 - Fluidic systems, devices and methods for inducing anisotropy in polymeric materials (2024-10-01),

4. 11634408 - Aryl hydrocarbon receptor modulators and uses thereof (2023-04-25),

5. 11027474 - Fluidic systems, devices and methods for inducing anisotropy in polymeric materials (2021-06-08),

6. 10253071 - Selectin inhibitors, composition, and uses related thereto (2019-04-09),

7. 9035028 - Temperature sensitive conjugate compositions (2015-05-19),

8. 8846624 - Modified protein polymers (2014-09-30),

9. 7833978 - Thrombomodulin derivatives and conjugates (2010-11-16),

10. 7824672 - Method for coating living cells (2010-11-02),

11. 7713544 - Biological component comprising artificial membrane (2010-05-11),

12. 7244830 - Glycopolymers and free radical polymerization methods (2007-07-17),

13. 6936298 - Antithrombogenic membrane mimetic compositions and methods (2005-08-30),

14. 6699952 - Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof (2004-03-02),

15. 6583251 - Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof (2003-06-24),

Title: Innovations and Achievements of Elliot L Chaikof

Introduction

Elliot L Chaikof is a prominent inventor located in Atlanta, GA, who has made significant contributions to the fields of medicine and biotechnology. With a remarkable total of 19 patents to his name, Chaikof's work primarily focuses on developing innovative therapies to combat various diseases and conditions.

Latest Patents

Among his latest patents are the following notable inventions:

1. **Selectin Inhibitors, Composition, and Uses Related Thereto**: This patent discusses selectin inhibitors, compositions, and pertinent methodologies. It specifically highlights glycopeptides that incorporate one or more modified amino acids conjugated to a saccharide or polysaccharide. The utility of these glycopeptides as anti-inflammatory, antithrombotic, or anti-metastatic agents is a significant focus.

2. **Aryl Hydrocarbon Receptor Modulators and Uses Thereof**: This patent introduces compounds formulated under criteria defined in the document, which may serve as aryl hydrocarbon receptor agonists or partial agonists. It also elaborates on pharmaceutical compositions containing these compounds and their applications in treating various conditions related to aryl hydrocarbon receptor activity, including inflammatory, autoimmune, metabolic, and proliferative diseases.

Career Highlights

Throughout his career, Elliot L Chaikof has been associated with renowned institutions such as Emory University and Beth Israel Deaconess Medical Center. His experiences at these organizations have greatly influenced his innovative approaches and research endeavors.

Collaborations

Chaikof has collaborated with notable professionals including Lijun Sun and June Feng. These collaborative efforts have undoubtedly enriched his research initiatives and propelled his projects forward, leading to impactful discoveries.

Conclusion

Elliot L Chaikof’s contributions to the field of medicine through his patents exemplify the power of innovation in addressing critical health challenges. His ongoing research and collaborations continue to pave the way for future advancements and therapeutic solutions.

Profile summary based on public USPTO records.